How Molecular Engines Fuel Pancreatic Cancer's Identity

Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat, largely because its cells possess 'lineage plasticity'—the ability to shift identities to adapt and survive. Researchers have identified a protein named KLF5 as a master regulator of this process, controlling whether cells adopt a 'classical' or 'basal-like' state. However, KLF5 cannot act alone.

The study reveals that KLF5 depends on two helper proteins, RUVBL1 and RUVBL2. These belong to a class of enzymes known as AAA+ ATPases, which function like molecular motors. The research demonstrates that RUVBL1 and RUVBL2 must burn ATP—the cell's energy currency—to stabilise a disordered region of the KLF5 protein. This energy-dependent interaction allows KLF5 to attach to specific sections of DNA, switching on genes that define the tumour's identity.

Crucially, the team found that small-molecule inhibitors designed to block the fuel-burning activity of RUVBL1/2 successfully suppressed KLF5-dependent transcription. This halted the cancer's ability to maintain its lineage programmes in vivo, highlighting a potential therapeutic strategy for modulating these aggressive tumours.